[Cytomegalovirus infections]

Area of Science:

• Virology and Infectious Diseases
• Immunocompromised Patient Care
• Maternal and Child Health

Background:

• Cytomegalovirus (CMV) infections are prevalent, often asymptomatic in children, but can manifest severely in adults, even the immunocompetent.
• CMV poses significant risks, causing morbidity and mortality in transplant recipients and potential neurosensory damage in congenital infections.
• Current diagnostic methods include serology for primary infections and PCR for monitoring in immunocompromised patients.

Purpose of the Study:

• To review the clinical spectrum and diagnostic approaches for Cytomegalovirus (CMV) infections.
• To highlight the challenges in managing CMV, particularly in vulnerable populations.
• To discuss emerging therapeutic strategies for CMV infections.

Main Methods:

• Review of current diagnostic techniques for Cytomegalovirus (CMV) infection.
• Analysis of clinical manifestations across different patient groups (children, adults, transplant recipients, pregnant women).
• Evaluation of existing and novel therapeutic interventions for CMV.

Main Results:

• Cytomegalovirus (CMV) diagnosis relies on serology for primary infections and PCR for monitoring in immunocompromised individuals.
• Congenital CMV infection screening is not routinely recommended but performed in specific clinical contexts.
• Existing therapies for CMV have limitations, including potential toxicities.

Conclusions:

• Cytomegalovirus (CMV) management requires tailored approaches based on patient status and infection type.
• Early diagnosis and intervention are crucial, especially for congenital CMV and in immunocompromised hosts.
• Emerging antivirals like maribavir and letermovir show promise for improving Cytomegalovirus (CMV) treatment outcomes.